Results: We studied the prognostic and predictive value of MAP17 (PDZK1IP1) expression in pancreatic cancer, and we found that high MAP17 mRNA expression was associated with poor prognosis. The gene discussed is PDZK1IP1; the disease is pancreatic neoplasm.